Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Upd

Data shared today in abstracts from the International Conference on Malignant Lymphoma (ICML) Both programs continue to demonstrate substantial target knockdown in ongoing clinical trials, with no dose

Related Keywords

Watertown , Massachusetts , United States , Lugano , Ticino , Switzerland , Boston , Bruce Jacobs , Parco Ciani , Todd Cooper , Adam Olszewski , Chris Brinzey , International Conference On Malignant Lymphoma , Exchange Commission , Kymera Therapeutics Inc , Lifespan Cancer Institute , Corporate Affairs , Nasdaq , Boston Globe , International Conference , Malignant Lymphoma , Refractory Lymphomas , Large Granular Lymphocytic Leukemia , Marquee Parco , Rhode Island , Fierce Biotech , Boston Business Journal , Private Securities Litigation Reform Act , Kymera Therapeutics , Kymera Therapeutic , Quarterly Report , Vice President ,